These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35498119)

  • 21. Synergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing.
    Howerton E; Ferrari MJ; Bjørnstad ON; Bogich TL; Borchering RK; Jewell CP; Nichols JD; Probert WJM; Runge MC; Tildesley MJ; Viboud C; Shea K
    PLoS Comput Biol; 2021 Oct; 17(10):e1009518. PubMed ID: 34710096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling and predicting the effect of social distancing and travel restrictions on COVID-19 spreading.
    Parino F; Zino L; Porfiri M; Rizzo A
    J R Soc Interface; 2021 Feb; 18(175):20200875. PubMed ID: 33561374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
    Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories.
    Ge Y; Zhang WB; Wu X; Ruktanonchai CW; Liu H; Wang J; Song Y; Liu M; Yan W; Yang J; Cleary E; Qader SH; Atuhaire F; Ruktanonchai NW; Tatem AJ; Lai S
    Nat Commun; 2022 Jun; 13(1):3106. PubMed ID: 35661759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inferring the effective start dates of non-pharmaceutical interventions during COVID-19 outbreaks.
    Kohanovski I; Obolski U; Ram Y
    Int J Infect Dis; 2022 Apr; 117():361-368. PubMed ID: 34986406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of non-pharmaceutical interventions on circulating respiratory viruses during the COVID-19 pandemic in Turkey.
    Kırca F; Aydoğan S; Gozalan A; Güler E; Uyan Erten AZ; Özşen Uygur AS; Doğan A; Dinc B
    Ann Saudi Med; 2023; 43(3):143-153. PubMed ID: 37270680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of behavioural interventions to influence COVID-19 outcomes: A scoping review.
    Silubonde-Moyana TM; Draper CE; Norris SA
    Prev Med; 2023 Jul; 172():107499. PubMed ID: 37028526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating local outbreak risks and the effects of non-pharmaceutical interventions in age-structured populations: SARS-CoV-2 as a case study.
    Lovell-Read FA; Shen S; Thompson RN
    J Theor Biol; 2022 Feb; 535():110983. PubMed ID: 34915042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive mathematical modelling.
    Rowan NJ; Moral RA
    Sci Total Environ; 2021 Jun; 772():145530. PubMed ID: 33581526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study.
    Zhang W; Wu Y; Wen B; Zhang Y; Wang Y; Yin W; Sun S; Wei X; Sun H; Zhang Z; Li S; Guo Y
    Infect Dis Poverty; 2023 Mar; 12(1):15. PubMed ID: 36895021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effects of Non-pharmaceutical Interventions on COVID-19 Mortality: A Generalized Synthetic Control Approach Across 169 Countries.
    Mader S; Rüttenauer T
    Front Public Health; 2022; 10():820642. PubMed ID: 35444988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to
    Boyanton BL; Frenner RA; Ingold A; Ambroggio L; Kennedy JL
    Microbiol Spectr; 2024 Apr; 12(4):e0290823. PubMed ID: 38488365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virological evidence of the impact of non-pharmaceutical interventions against COVID-19 in Ecuador, a resource-limited setting.
    Moreira-Soto A; Bruno A; de Mora D; Paez M; Garces J; Wulf B; Sander AL; Olmedo M; Basantes Mantilla MJ; Gonzalez Gonzalez M; Orlando SA; Salgado Cisneros S; Zevallos JC; Drexler JF
    Emerg Microbes Infect; 2023 Dec; 12(2):2259001. PubMed ID: 37698611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.
    Mendez-Brito A; El Bcheraoui C; Pozo-Martin F
    J Infect; 2021 Sep; 83(3):281-293. PubMed ID: 34161818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accessing the syndemic of COVID-19 and malaria intervention in Africa.
    Shi B; Zheng J; Xia S; Lin S; Wang X; Liu Y; Zhou XN; Liu J
    Infect Dis Poverty; 2021 Jan; 10(1):5. PubMed ID: 33413680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of multiple non-pharmaceutical interventions for China-bound travel on domestic COVID-19 outbreaks.
    Yang L; Hu M; Zeng H; Liang W; Zhu J
    Front Public Health; 2023; 11():1202996. PubMed ID: 37521963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceptions of the ethical permissibility of strict travel restrictions to mitigate transmission of SARS-CoV-2.
    Hartsock JA; Head KJ; Kasting ML; Sturm L; Zimet G
    Transp Res Interdiscip Perspect; 2022 Jun; 14():100577. PubMed ID: 35252841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of serological surveys of antibodies to SARS-CoV-2 in the United States to estimate parameters needed for transmission modeling and to evaluate and improve the accuracy of predictions.
    Glasser JW; Feng Z; Vo M; Jones JN; Clarke KEN
    J Theor Biol; 2023 Jan; 556():111296. PubMed ID: 36208669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 prevention and control effect of non-pharmaceutical interventions-fuzzy-sets qualitative comparative analysis based on 69 countries in the world.
    Yang C; Li Q; Zhao Z; Chen Z; Guo H; Huang D; Yin W
    Front Public Health; 2024; 12():1419109. PubMed ID: 39131571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.